Ramiah Investment Group’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
FP
Ramiah Investment Group's MRNA Position: Q2 2024 in Review
Ramiah Investment Group sold out of Moderna (MRNA) in Q2 2024, closing a stake of 5,710 shares — an estimated $608K sold.
Ramiah Investment Group first reported a position in MRNA in Q3 2021 and held it in 5 quarters. The position peaked at $1.74M in Q3 2021. 954 funds tracked by Wall St. Rank hold MRNA as of Q2 2024.
- Ramiah Investment Group reported no remaining Moderna position as of Q2 2024 after selling out during the quarter.
- Ramiah Investment Group sold 5,710 Moderna shares in Q2 2024, an estimated $608K.
- Ramiah Investment Group first reported a position in Moderna in Q3 2021 and held it in 5 quarters.
- Ramiah Investment Group's Moderna position peaked at $1.74M in Q3 2021.
- 954 funds tracked by Wall St. Rank held Moderna as of Q2 2024.
Based on Ramiah Investment Group's 13F filing for Q2 2024, filed 29 May 2026.